Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited-Stage Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01707888
What this trial is testing

VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Peking University People's Hospital 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07722182
What this trial is testing

Navigation Bronchoscopy Guided Microwave Ablation Versus SBRT in Early NSCLC

Who this might be right for
Lung Cancer (NSCLC)
Chinese University of Hong Kong 100
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Not applicableStudy completedNCT05785845
What this trial is testing

Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer

Who this might be right for
Early Stage Non-small Cell Lung CancerNon-small Cell Lung Cancer
Washington University School of Medicine 17
Not applicableStudy completedNCT07050472
What this trial is testing

Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)

Who this might be right for
Small-cell Lung Cancer
Anhui Shi, MD 45
Not applicableUnknownNCT03414944
What this trial is testing

Elective Simultaneous Modulated Accelerated Brain Radiation Therapy for NSCLCs With Limited Brain Metastases

Who this might be right for
Brain Metastases
Shandong Cancer Hospital and Institute 30
Large-scale testing (Phase 3)Study completedNCT02998528
What this trial is testing

A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Bristol-Myers Squibb 505
Testing effectiveness (Phase 2)Active Not RecruitingNCT05617963
What this trial is testing

Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax

Who this might be right for
Small Cell Lung Carcinoma
UNICANCER 100
Testing effectiveness (Phase 2)Looking for participantsNCT06562920
What this trial is testing

Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer

Who this might be right for
Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer
Zhejiang Cancer Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06483282
What this trial is testing

Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Limited Stage
Jin Ying 38
Testing effectiveness (Phase 2)Study completedNCT00033696
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 65
Early research (Phase 1)Study completedNCT00014066
What this trial is testing

Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT07815223
What this trial is testing

A Phase II Study of Tislelizumab Plus Anlotinib Consolidation After Chemoradiotherapy in LS-SCLC

Who this might be right for
SCLC, Limited Stage
Yantai Yuhuangding Hospital 20
Large-scale testing (Phase 3)UnknownNCT00519805
What this trial is testing

Dalteparin in Preventing Blood Clots in Patients With Lung Cancer

Who this might be right for
Lung CancerThromboembolism
Velindre NHS Trust 2,200
Testing effectiveness (Phase 2)UnknownNCT02738723
What this trial is testing

SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC

Who this might be right for
Small Cell Lung Cancer
Third Military Medical University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06256237
What this trial is testing

Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial

Who this might be right for
Limited Stage Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03833154
What this trial is testing

Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 724
Very early researchWithdrawnNCT03574220
What this trial is testing

Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT04530227
What this trial is testing

Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC

Who this might be right for
Early Stage Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableStudy completedNCT04808050
What this trial is testing

Real-world Treatment Patterns and Associated Outcomes in Patients With Resectable Early-stage Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 748
Next Page